Samarium-¹⁵³–Lexidronam Therapy for Metastatic Bone Pain

ABSTRACT

Multidisciplinary management may offer alternative therapeutic strategies in patients. Bone-seeking radiopharmaceuticals offered alongside traditional approaches to analgesia may be useful in the treatment of metastatic bone pain. A case of metastatic bone pain in which ¹⁵³Sm-lexidronam therapy was used is presented. Minimal side effects, as well as a reduction in opioid use (via patient-controlled analgesia), were observed in this case.

KEYWORDS :

• bone
• mnetastatic
• pain
• radiopharmaceutical
• ¹⁵³Sm-lexidronam

Notes

Emeritus Professor Ostin Mungiu is the Director, Centre for the Study and Therapy of Pain, Grigore T Popa University of Medicine and Pharmacy, Iasi, Romania.

Professor Giuliano Mariani is Director, Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa, Italy.